Share:
Peer-Reviewed Publication
Heart Rhythm O22026;7(2):390-392.February 1, 2026Journal Article

Artificial intelligence-guided personalized ablation improves freedom from atrial arrhythmia in heart failure: A sub-analysis of the TAILORED-AF trial.

Dhanunjaya Lakkireddy1, Stavros Mountantonakis2, Seth Goldbarg3, John D Hummel4, Haroon Rashid5, Julien Seitz6,7, Paola Milpied6, Sabine Lotteau6, Isabel Deisenhofer8, Jerome Kalifa6
1The Kansas City Heart Rhythm Institute, Overland Park, Kansas.
2Northwell Cardiovascular Institute, New Hyde Park, New York.
3New York Presbyterian Queens Division of Cardiology, Flushing, New York.
4The Ohio State University Wexner Medical Center, Columbus, Ohio.
5Inova Heart and Vascular Institute and Virginia Heart Fairfax, Virginia.
6Volta Medical, Marseille, France.
7Hôpital Saint Joseph, Marseille, France.
8Department of Electrophysiology, Technical University of Munich (TUM), German Heart Center Munich, Munich, Germany.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.